Tag Archives: Roger Millichamp

APO-Valsartan product recall

Apotex, in consultation with the TGA, is recalling all batches and strengths of the company’s supplied APO-Valsartan tablet blister packs due to the presence of trace elements of an impurity. The products being recalled comprise: • APO-Valsartan 40mg tablets (AUST R 185806). • APO-Valsartan 80mg tablets (AUST R 185814). • …

Read More »

TWC’s new initiatives

TerryWhite Chemmart’s largest conference ever, with more than 560 registered attendees, formally began in Sydney last Sunday (August 26) with the announcement of a new advisory group. The conference offered insights on future pharmacy and digital trends shared by an expert industry panel including Ebos CEO John Cullity and Apotex …

Read More »

Arrow and Apotex Australia to merge

Arrow Pharmaceuticals and Apotex have announced a proposed merger of their Australian and New Zealand generic pharmaceutical and OTC operations. The proposed merger, still subject to several conditions, including ACCC approval and due diligence, aims to create a sustainable platform for growth and development of the companies’ business interests in …

Read More »